Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Comment by Tunee70on Jun 21, 2015 12:39pm
201 Views
Post# 23853055

RE:Thompson Reuters Projected Revenue..

RE:Thompson Reuters Projected Revenue..They're at $115 million right now with 50 million in Loi's expected to close which would put them at $165 million. 
Sleep co should get to about $60 million through their own organic growth before any cross-selling into their database or selling their product into the existing database which would put it at $185 million.
Should easily hit $200 million with a very small amount of organic growth and that is being very conservative. The m&a team still has 6 months to go and alot of cash.  If they continue to execute as they have in the first 6 months they have the potential to beat all estimates handily.  
The conference call could be very interesting, i expect updated guidance but its hard to say what it will be as they always underpromise.

Bullboard Posts